MS Phase 3 Study DECIDE: uses & side-effects

PatientsLikeMe would like to remind you that your browser is out of date and many features of the website may not function as expected. Please update your browser for more security and a better experience.

Skip over navigation

Filter by patients with:

Start typing to see suggestions

What is MS Phase 3 Study DECIDE?

Category: Others

See also: Clinical Trial

DECIDE is a Phase III, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) Versus Avonex® (Interferon β 1a) in Patients With Relapsing-Remitting Multiple Sclerosis.

See patients taking MS Phase 3 Study DECIDE

Last updated: April 26, 2026

There are no evaluations for MS Phase 3 Study DECIDE.

▲ Back to top